Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SUMATRIPTAN | 25MG | TABLET | Resolved | 2023-09-11 | 2023-10-11 | 204095 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2017-06-02 | 2019-08-23 | 11788 |
| MYLAN-TADALAFIL | 2.5MG | TABLET | Resolved | 2017-08-10 | 2018-12-19 | 18688 |
| MYLAN-TADALAFIL | 5MG | TABLET | Resolved | 2018-04-13 | 2019-08-23 | 45590 |
| MYLAN-TADALAFIL | 10MG | TABLET | Resolved | 2019-01-30 | 2019-06-19 | 73957 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2019-09-19 | 2020-03-04 | 94402 |
| MYLAN-TADALAFIL | 5MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94761 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2022-01-13 | 2022-07-12 | 152654 |
| MYLAN-TADALAFIL | 20MG | TABLET | Avoided shortage | 2023-09-20 | 2023-09-26 | 204802 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-17 | 2023-12-19 | 207187 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Resolved | 2018-06-06 | 2018-08-11 | 51615 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Resolved | 2018-06-06 | 2018-08-11 | 51621 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Resolved | 2018-01-02 | 2018-08-29 | 34559 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2019-02-21 | 2019-03-05 | 76496 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2020-05-26 | 2020-06-03 | 115765 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2022-12-08 | 2023-02-06 | 177336 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-08-01 | 2022-02-15 | 17787 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-10-13 | 2022-02-15 | 25895 |
| MYLAN-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2024-04-01 | 2024-04-23 | 224061 |
| MYLAN-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-03-07 | 2018-04-28 | 42157 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |